Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Boehringer Ingelheim International
Current Parent Company: Boehringer Ingelheim
Penalty: $650,000,000
Year: 2014
Date: May 28, 2014
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: product safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: Boehringer Ingelheim agreed to pay $650 million to settle multi-district litigation alleging that its blood thinner Pradaxa caused harms such as severe bleeding: (click here)
Level of Government: federal
Action Type: private litigation
Court: Southern District of Illinois
Civil or Criminal Case: civil
Case ID: 3:12md2385
Case Name: In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Germany
Ownership Structure of Current Parent: privately held
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.